Thursday, October 8

Money

This downturn can be attributed to several factors: a lowered guidance for 2025 and growing concerns about the long-term growth prospects of its…

However, this abrupt rally appears to be a singular occurrence – competitors such as Pfizer (NYSE: PFE), Sarepta Therapeutics (NASDAQ: SRPT), and…

This represents one of the steepest daily selloffs in the stock’s history and brings UNH to levels not seen in five years.

© 2026 The Money Times. All rights reserved